MIR-125B, MIR-100 AND MIR-99A CO-REGULATE VINCRISTINE RESISTANCE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA

被引：0
|
作者：
Moqadam, F. Akbari [1 ]
Lange-Turenhout, E. A. M. [1 ]
Aries, I. M. [1 ]
Pieters, R. [1 ]
Den Boer, M. L. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Rotterdam, Netherlands
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia
    Moqadam, F. Akbari
    Lange-Turenhout, E. A. M.
    Aries, I. M.
    Pieters, R.
    den Boer, M. L.
    LEUKEMIA RESEARCH, 2013, 37 (10) : 1315 - 1321
  • [2] Collaboration Between MiR-125b, MiR-100 and MiR-99a Induces Vincristine Resistance in Childhood TEL-AML1-Positive Acute Lymphoblastic Leukemia
    Moqadam, Farhad Akbari
    Lange-Turenhout, Ellen
    Pieters, Rob
    Den Boer, Monique L.
    BLOOD, 2012, 120 (21)
  • [3] miR-100 and miR-125b induce cetuximab resistance in CRC
    Hugh Thomas
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 691 - 691
  • [4] miR-100 and miR-125b induce cetuximab resistance in CRC
    Thomas, Hugh
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (12) : 691 - 691
  • [5] The expression of miR-125b and miR-100 in OSCC and their contribution to malignancy
    Henson, Brian
    Bhattacharjee, Samsiddhi
    O'Dee, Dawn
    Feingold, Eleanor
    Gollin, Susanne
    CANCER RESEARCH, 2009, 69
  • [6] Characterizing invasiveness in CCCR cells: Role of miR-100, miR-125b and EVs
    Shameer, Muhammad
    Nelson, Hannah M.
    Qu, Shimian
    Huang, Liyu
    Corn, Kevin C.
    Chapman, Sydney N.
    Luthcke, Nicole L.
    Schuster, Sara A.
    Stamaris, Tellie D.
    Turnbull, Lauren A.
    Guy, Lucas L.
    Liu, Xiao
    Michell, Danielle L.
    Semler, Elizabeth M.
    Vickers, Kasey C.
    Liu, Qi
    Franklin, Jeffrey L.
    Weaver, Alissa M.
    Rafat, Marjan
    Coffey, Robert J.
    Patton, James G.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (11)
  • [7] IncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
    Lu, Yuanyuan
    Zhao, Xiaodi
    Liu, Qi
    Li, Cunxi
    Graves-Deal, Ramona
    Cao, Zheng
    Singh, Bhuminder
    Franklin, Jeffrey L.
    Wang, Jing
    Hu, Huaying
    Wei, Tianying
    Yang, Mingli
    Yeatman, Timothy J.
    Lee, Ethan
    Saito-Diaz, Kenyi
    Hinger, Scott
    Patton, James G.
    Chung, Christine H.
    Emmrich, Stephan
    Klusmann, Jan-Henning
    Fan, Daiming
    Coffey, Robert J.
    NATURE MEDICINE, 2017, 23 (11) : 1331 - +
  • [8] lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
    Yuanyuan Lu
    Xiaodi Zhao
    Qi Liu
    Cunxi Li
    Ramona Graves-Deal
    Zheng Cao
    Bhuminder Singh
    Jeffrey L Franklin
    Jing Wang
    Huaying Hu
    Tianying Wei
    Mingli Yang
    Timothy J Yeatman
    Ethan Lee
    Kenyi Saito-Diaz
    Scott Hinger
    James G Patton
    Christine H Chung
    Stephan Emmrich
    Jan-Henning Klusmann
    Daiming Fan
    Robert J Coffey
    Nature Medicine, 2017, 23 : 1331 - 1341
  • [9] Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
    Vergani, Elisabetta
    Di Guardo, Lorenza
    Dugo, Matteo
    Rigoletto, Sara
    Tragni, Gabrina
    Ruggeri, Roberta
    Perrone, Federica
    Tamborini, Elena
    Gloghini, Annunziata
    Arienti, Flavio
    Vergani, Barbara
    Deho, Paola
    De Cecco, Loris
    Vallacchi, Viviana
    Frati, Paola
    Shahaj, Eriomina
    Villa, Antonello
    Santinami, Mario
    De Braud, Filippo
    Rivoltini, Licia
    Rodolfo, Monica
    ONCOTARGET, 2016, 7 (04) : 4428 - 4441
  • [10] miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment
    Despina Piatopoulou
    Margaritis Avgeris
    Antonios Marmarinos
    Marieta Xagorari
    Margarita Baka
    Dimitrios Doganis
    Lydia Kossiva
    Andreas Scorilas
    Dimitrios Gourgiotis
    British Journal of Cancer, 2017, 117 : 801 - 812
12345